Solve ME/CFS Initiative (SMCI) has a regular free Webinar Series, which has the purpose of educating patients, researchers, and healthcare providers about ME/CFS. The webinars are held several times per year, and are live-streamed and later uploaded to Youtube for the community to watch. On December 6, 2018 at 10 am PT, SMCI’s Chief Scientific Officer (CSO), Sadie Whittaker, will be participating in the series.

Sadie’s webinar, titled “You + M.E.: A community resource, built by the community,” will focus on the SMCI Biobank and the redesign of its current process, plus their new patient registry. These are resources that SMCI hopes will reflect the needs and priorities of individuals suffering from ME/CFS. Participants can register for the webinar on SMCI’s website, as well as send in questions ahead of time that will be asked during the webinar.

To register for the webinar on SMCI’s website, click here. 

One of the missions of our clinical core at Bateman Horne Center (BHC) in Salt Lake City, UT is to educate patients, doctors, and researchers about ME/CFS and Fibromyalgia (FM). In honor of Dr. Lucinda Bateman’s birthday on November 9th, BHC has launched a digital patient education series. The purpose of this series is to help patients learn more about different aspects of ME/CFS so that they can take these principles to their primary care providers (PCPs).

The video series will cover fundamental issues in ME/CFS through six videos, released weekly for six weeks, and include topics such as getting the right diagnosis, cognitive impairment, restorative sleep, and others. After signing up, a link will be sent by email to allow access to the videos. The second video will be released on November 16th, and will cover “Activity Intolerance and Post-Exertional Malaise (PEM).”

Click here to sign up for the series on BHC’s website.
Click here to read BHC’s blog post about the video series. 

A new study in PNAS has linked the interaction between the intestinal epithelial barrier, the gut microbiome, and immune cells to intestinal inflammation. It is thought that the gut microbiota and immune cells contribute to gut inflammation, but until now, it has been difficult to identify exactly what triggers the onset of intestinal inflammation due to the complexity of the cross-talk between the multiple different cell types.

Continue reading “‘Gut-on-a-chip’ System Shows Intestinal Epithelial Barrier Disruption Initiates Gut Inflammation” →